Process Validation in the Twenty-First Century

Helen Strickland,Stan Altan

DOI: https://doi.org/10.1007/978-3-319-23558-5_19

2016-01-01

Abstract:Process validation is a continuous series of activities that are aligned to the product lifecycle; it is no longer a one-off activity. The process validation lifecycle consists of three major stages: (1) process design, (2) process qualification, and (3) continued process verification. Each stage corresponds to an increasing level of scientific understanding of the product and the manufacturing process. A systematic process validation plan integrates science, risk management, and statistics to collect and evaluate appropriate data throughout the product lifecycle. The process validation plan must fulfill the requirement to provide documented evidence of the manufacturing process’ ability to consistently produce finished drug product that meets specifications in relation to identity, strength, quality and purity. The evidence is established through statistical tools that seek to identify, detect and control sources of variation that impact on the critical quality attributes of the finished drug product. Acceptance sampling, tolerance intervals, control charting and sample size justification through standard and Bayesian approaches are fundamental elements of a comprehensive lifecycle approach to process validation. This chapter provides an overview of regulatory and statistical aspects of process validation as set forth in the 2011 FDA guidance on process validation and other guidances with emphasis on Stage 2—Process Performance Qualification and Stage 3—Continuous Process Verification.